Table 2 Cases of cerebral vasospasm after rupture of a BAVM, adapted from Yanaka et al. [3] and Gerard et al. [7]
Clinical and radiological features | BAVM angioarchitectural features | BAVM treatment | Vasospasm features and management | Outcome | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# | Sex | GCS | SAH | IVH | ICH | Location | Venous drainage | Size (mm) | Eloquence | Spetzler Martin Grade | Co-existing aneurism | BAVM treatment | Exclusion | Time to treatment | Time to onset (days) | TCD Mean flow velocity (cm/s) | TCD-VS artery | CI location | Medical treatment | Endovascular treatment | GOS | Causes of death |
1 | M | 4 | A | Y | N | R. frontal | Superf. | <30 | N | 1 | N | None | - | - | 11 | 200 | B MCA | L ACA L MCA | Nimodipine | IA Nimodipine | 1 | Cerebral ischemia |
2 | F | 3 | F | Y | Y | R. temporal | Superf. | 30 to 60 | N | 2 | N | Surgery | Total | <24 h | 9 | 160 | B MCA | None | None | 2 | - | |
3 | M | 3 | F | Y | Y | R. frontal | Deep | >60 | Y | 5 | N | None | - | - | 10 | 150 | B MCA | R MCA R ACA L MCA | None | None | 1 | Intracranial hypertension |
4 | F | 3 | D | Y | Y | Cerebellum | Superf. | <30 | Y | 2 | N | Surgery | Total | <24 h | 6 | 169 | B MCA R ACA L VA, BA | None | None | 1 | Intracranial hypertension | |
5 | M | 10 | A | N | Y | Cerebellum | Superf. | <30 | Y | 2 | N | Surgery | Total | <24 h | 4 | 150 | B MCA B ACA | Nimodipine | None | 2 | - | |
6 | M | 4 | D | Y | Y | R. parietal | Deep | 30 to 60 | N | 3 | N | Surgery | Total | <24 h | 7 | 222 | L MCA | Nimodipine | IA Nimodipine IA Milrinone | 1 | Initial bleed | |
7 | F | 7 | A | Y | Y | L. parietal | Deep | <30 | N | 2 | Intranidal | None | - | - | 13 | 165 | B MCA | R MCA | Nimodipine | None | 3 | - |
8 | F | 7 | F | Y | Y | Posterior cranial fossa | Superf. | <30 | N | 1 | N | Surgery | Total | <24 h | 11 | 162 | B MCA | B MCA B PCA | None | IA Nimodipine IA Milrinone | 1 | Cerebral ischemia |
9 | F | 13 | D | Y | N | L. frontal | Deep | <30 | Y | 3 | N | Embolization | Total | 5 d | 9 | 160 | R MCA | R MCA RACA | Nimodipine | IA Nimodipine IA Milrinone | 2 | - |
10 | F | 5 | A | Y | Y | R. frontal | Deep | <30 | Y | 3 | N | Surgery | Total | <24 h | 4 | 194 | B MCA R ACA | L MCA | Nimodipine | None | 3 | - |
11 | F | 3 | D | Y | Y | R. frontal | Deep | >60 | Y | 5 | N | Embolization | Incom-plete | <24 h | 11 | 185 | B MCA B ACA | Nimodipine | None | 5 | - | |
12 | M | 8 | A | N | Y | R. parietal | Deep | 30 to 60 | Y | 4 | N | None | - | - | 4 | 217 | R MCA | Nimodipine | None | 3 | - | |